Market Analysis - (2019) Volume 13, Issue 4
Global presence of your research at Genetic disorders 2020 scheduled during May 18-19, 2020 Auckland, New Zealand.
Market Analysis
Genetic disorders 2020 welcomes attendees, presenters, and exhibitors from all over the world to Auckland, New Zealand. We are delighted to invite you all to attend and register for the “International Conference on Genetic Disorders and Gene Therapy” which is going to be held during May 18-19, 2020 Auckland, New Zealand. The Organizing Committee is gearing up for an thrilling and informative conference program with plenary talks, symposia, workshops on a variety of topics, poster presentations and many programs for members from all over the world. We invite you to join us at the Genetic disorders 2020, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Genetic disorders 2020 Organizing Committee will look forward to meet you at Auckland, New Zealand.
The global market for Genetic Disorders is forecast to reach US$2.4 billion by 2018. Increasing knowledge about the potential benefits in genetic Therapy is one of the prime reasons for the growth of the genetic testing market. Advancements in the genetic testing space, aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.
The regional analysis includes North America, Europe, Asia Pacific, Middle East and rest of the world.
The rise of growth rate is due to increase in technological advancement and various measures taken by US government to expand the national DNA databases.
The Duchene Muscular Dystrophy (DMD) treatment market is expected to change radically by 2019 in the six major pharmaceutical markets.
Generic corticosteroids, namely prednisone and deflazacort, remain the current standards of care and contribute to the nascent DMD market, which was estimated at $8.2 million across the 6MM in 2014. However, both the treatment landscape and the DMD market are set to witness tremendous growth—reaching nearly $1 billion by 2019—as a result of the launch of novel mutation-specific drugs in the coming years. However, a large segment of DMD patients are expected to be ineligible for these promising new drugs, leaving vast opportunity for developers to deliver new therapies and for continued growth in the DMD market beyond 2019.
Today’s Market Study Genetic Disorders in USA | Europe | Middle East | Asia Pacific
Asia pacific: The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. The primary growth engine in this region is China, which is expected to register a growth rate of 13.2% in the forecast period.
USA: The USA Genetics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020.
Europe: The Europe genetic Therapy market is estimated at USD 1.22 billion in 2016, and is projected to reach USD 1.8 billion by 2021, growing with a compound annual growth rate (CAGR) of 8.2% during the forecast period, 2016-2021.
Middle East: The global Human Genetics identification market was valued at an estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years.
USA: Approximately, more than 24285 members involved in Genetics and related researches.
Europe: Approximately, more than 56083 members involved in Genetics and related researches.
Global: Approximately, 1291100 members involved in Genetics and related researches.
Behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.
Competitive Market Share Insights:
• Brook dale Senior Living, Inc.,
• Sunrise Senior Living, Inc.,
• Emeritus Corporation,
• Atria Senior Living Group,
• Extendicare, Inc.,
• Genitive Health Services, Inc.,
• Senior Care Centers of America,
• Kindred Healthcare, Inc.,
• Genesis Healthcare Corp.,
• Home Instead Senior Care, Inc.
• Statistics which shows Market growth:
Importance & Scope:
Conference on Genetic disorders and Gene Therapy is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students to come and inform all the attendees about the latest scientific advancements on the respective sphere.
Target Audience:
• Medical Research Laboratories
• Academic Medical Institutes and Universities
• Research and Development Companies
• Genetics & Genomic Industries
• Scientists
• Professors
• Young Researchers
• Students
• Technical Staff
Related Associations and Societies:
• British Society of Gene Therapy (BSGT)
• Netherlands Society of Gene and Cell Therapy (NVGCT)
• Thai Society for Biotechnology (TSB)
• European Sales & Marketing Association (ESMA)
• Austrian Network for Gene Therapy
• French Society of Cellular and Gene Therapy (SFTCG)
• Biotechnology entrepreneurs
• European Calcified Tissue Society
• Latin American Society of Genetics (ALAG)
• Human Genetics Society of Australasia (HGSA)
• European Society of Gene Therapy (ESGT)
• Genetic Society of Australia (GSA)
• Genetics Society of Korea (GSK)
Contact Person:
Lisa Fernandes | Event Manager
Conference series LLC
Email: transplantscience@asia-meetings.com
Whatsapp: +44-1772368008
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report
